SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No.2)

CV THERAPEUTICS INC

(Name of issuer)

CCOMMON STOCK, $0.001 PAR VALUE PER SHARE

(Title of class of Securities)

126667104
(CUSIP Number)

31 December 2008

(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
[ ] Rule 13d-l(b)
[(] Rule 13d-l(c)
[ ] Rule 13d-l(d)
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP NO. 126667104 Page 2 of 6 Pages
1. NAME OF REPORTING PERSON

 ROSS FINANCIAL CORPORATION
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
 (b) [ ]
3. SEC USE ONLY
4. CITIZENSHIP OR PLACE OF ORGANIZATION
 CAYMAN ISLANDS
NUMBER OF
5. SOLE VOTING POWER -0-
SHARES

BENEFICIALLY
6. SHARED VOTING POWER 5,047,280
OWNED BY

EACH
7. SOLE DISPOSITIVE POWER -0-
REPORTING

PERSON
8. SHARED DISPOSITIVE POWER 5,047,280
WITH

9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,047,280 shares
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) [ ]
 EXCLUDES CERTAIN SHARES*
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 8.2%
12. TYPE OF REPORTING PERSON*
 CO









CUSIP NO. 126667104 Page 3 of 6 Pages
1. NAME OF REPORTING PERSON

 KENNETH B. DART
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
 (b) [ ]
3. SEC USE ONLY
4. CITIZENSHIP OR PLACE OF ORGANIZATION
 CAYMAN ISLANDS
NUMBER OF
5. SOLE VOTING POWER -0-
SHARES

BENEFICIALLY
6. SHARED VOTING POWER 5,047,280
OWNED BY

EACH
7. SOLE DISPOSITIVE POWER -0-
REPORTING

PERSON
8. SHARED DISPOSITIVE POWER 5,047,280
WITH

9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,047,280 shares
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) [ ]
 EXCLUDES CERTAIN SHARES*
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 8.2%
12. TYPE OF REPORTING PERSON*
 IN









CUSIP No. 126667104 Page 4 of 6 Pages
ITEM l(a). NAME OF ISSUER:
 CV THERAPEUTICS INC
ITEM l(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
 3172 PORTER DRIVE
 PALO ALTO, CALIFORNIA 94304
ITEM 2(a). NAME OF PERSON FILING:
1) ROSS FINANCIAL CORPORATION
Ross Financial Corporation is a direct wholly owned
subsidiary of STS Inc., a Cayman Islands Company.
2) KENNETH B. DART
Mr. Dart is the beneficial owner of all of the outstanding
shares of STS Inc., which in turns owns all the outstanding
shares of Ross Financial Corporation.
ITEM 2(b). ADDRESS OF PRINCIPAL OFFICE:
 1) P.O. BOX 31363
 Grand Cayman KY1-1206 CAYMAN ISLANDS
 2) P.O. BOX 31300
 Grand Cayman KY1-1206 CAYMAN ISLANDS
ITEM 2(c). CITIZENSHIP:
1) Cayman Islands
2) Belize
ITEM 2(d). TITLE OF CLASS OF SECURITIES:
 Common Stock $.001 par value per share
ITEM 2(e). CUSIP NUMBER: 126667104
ITEM 3. Not Applicable.



CUSIP NO. 126667104 Page 5 of 6 pages

ITEM 4. OWNERSHIP
 As of the date of this filing, Ross Financial Corporation
 And Mr. Dart beneficially own in the aggregate the following:

(a) Amount Beneficially owned: 5,047,280
(b) Percent of Class: 8.2%
(c) Number of shares as to which the person has:
 (i) sole power to vote or to direct the vote: -0-
 (ii) shared power to vote or to direct the vote: 5,047,280
 (iii)sole power to dispose of or to direct the disposition of:
 -0-
 (iv) shared power to dispose of or to direct the disposition of:
 5,047,280

 Included in the above 5,047,280 shares beneficially owned by Ross
 Financial Corporation are 2,700,000 shares of CV Therapeutics in an
 account at Lehman Brothers Inc (LBI) which were subject to a pledge
 to Lehman Brothers Special financing Inc. (LBSP), as pledgee. We have
 been informed by LBI that these shares were rehypothecated and are no
 longer in the possession of LBI or LBSF. We have filed a claim to
 recover these 2,700,000 shares of CV Therapeutics Inc. from LBI.
 As a result of his beneficial ownership of all of the
 outstanding shares of STS Inc, which in turn owns all the outstanding
 shares of Ross Financial Corporation Mr. Dart is deemed to
 beneficially own the securities owned by Ross Financial Corporation.
ITEM 5. OWNERSHIP OF 5 PERCENT OR LESS OF A CLASS: [ ]
ITEM 6. OWNERSHIP OF MORE THAN 5 PERCENT ON BEHALF OF ANOTHER PERSON:
 Not Applicable
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY
WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE
PARENT HOLDING COMPANY OR CONTROL PERSON. Not applicable

CUSIP NO. 126667104 Page 6 of 6 pages

ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
Not applicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP. Not applicable.

ITEM 10. CERTIFICATION.
 By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were not acquired and
are not held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were
not acquired and are not held in connection with or as a participant
in any transaction having that purpose or effect.
 SIGNATURE.
 After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement
is true, complete and correct.

ROSS FINANCIAL CORPORATION
BY: Kenneth B. Dart, Director
13 February 2009



KENNETH B. DART
13 February 2009
??

??

??

??

 1

CV Therapeutics (NASDAQ:CVTX)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more CV Therapeutics Charts.
CV Therapeutics (NASDAQ:CVTX)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more CV Therapeutics Charts.